SCHEMBL8544793

SCHEMBL8544793

O=C1NC(=O)C(=Cc2cccs2)N1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 5/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PIM1 P11309 1/20 0.51
▸ CGAS Q8N884 1/20 0.50
▸ ADAMTS5 Q9UNA0 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.48
▸ MAPT P10636 3/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ LMNA P02545 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ BLM P54132 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NR1I2 O75469 1/20 0.45
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8544791 1.00 GSK3B (0.59) GSK3BSMN1; SMN2PIM1CGASADAMTS5
SCHEMBL1520384 0.83 PIM1 (0.56) GSK3BSMN1; SMN2PIM1ALDH1A1MAPT
SCHEMBL1520385 0.83 PIM1 (0.56) GSK3BSMN1; SMN2PIM1ALDH1A1MAPT
SCHEMBL1520382 0.83 PIM1 (0.56) GSK3BSMN1; SMN2PIM1ALDH1A1MAPT
SCHEMBL8209251 0.74 GSK3B (1.00) GSK3BSMN1; SMN2CGASMAPTRAB9A
SCHEMBL8209256 0.74 GSK3B (1.00) GSK3BSMN1; SMN2CGASMAPTRAB9A
SCHEMBL8209254 0.74 GSK3B (1.00) GSK3BSMN1; SMN2CGASMAPTRAB9A
SCHEMBL8616104 0.74 GSK3B (0.66) GSK3BSMN1; SMN2PIM1ADAMTS5ALDH1A1
SCHEMBL1250019 0.70 GSK3B (1.00) GSK3BSMN1; SMN2PIM1MAPTHPGD
SCHEMBL13848481 0.70 KMT2A (0.60) GSK3BSMN1; SMN2PIM1ADAMTS5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332829-A Process for reducing 5-(2-thenylidene) hydantoin to 5-(2-thenyl) hydantoin SOCIETE FRANCAISE HOECHST (FR) 1994-07-26 — — US claimed
JP-5255321-A — — None — — JP disclosed
EP-0695749-B1 Process for the selective hydrogenation of activated, ethylenically unsaturated compounds RUETGERS ORGANICS GMBH (DE) 1998-11-25 — — EP disclosed
EP-0695749-A1 Process for the selective hydrogenation of activated, ethylenically unsaturated compounds RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) 1996-02-07 — — EP disclosed
US-5332829-A Process for reducing 5-(2-thenylidene) hydantoin to 5-(2-thenyl) hydantoin SOCIETE FRANCAISE HOECHST (FR) 1994-07-26 — — US disclosed
US-5332829-A Process for reducing 5-(2-thenylidene) hydantoin to 5-(2-thenyl) hydantoin SOCIETE FRANCAISE HOECHST (FR) 1994-07-26 — — US disclosed
US-5332829-A Process for reducing 5-(2-thenylidene) hydantoin to 5-(2-thenyl) hydantoin SOCIETE FRANCAISE HOECHST (FR) 1994-07-26 — — US disclosed
JP-H05255321-A PRODUCTION OF 5-(2-THENYL)-HYDANTOIN SOC FR HOECHST 1993-10-05 — — JP disclosed
Send feedback